Clarithromycin
Motor Outcomes
National University of MalaysiaSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Motor Outcomes cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Amoxicillin National University of Malaysia | N/A | D |
Esomeprazole National University of Malaysia | N/A | D |
Same molecule, other indications
Clarithromycin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →